Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Enhanced antitumor efficacy, proliferative capacity, and alleviation of T cell exhaustion by fifth-generation chimeric antigen receptor T cells targeting B cell maturation antigen in multiple myeloma
Pornpimon Yuti, Nunghathai Sawasdee, Krissada Natungnuy, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 168, pp. 115691-115691
Open Access | Times Cited: 10

Showing 10 citing articles:

Adoptive T cell therapy for solid tumors: current landscape and future challenges
Víctor Albarrán, María San Román, Javier Pozas, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 17
CAR‐T cells in the treatment of multiple myeloma: an encouraging cell therapy
Tong Yu, Jianhang Jiao, Minfei Wu
Frontiers in Immunology (2025) Vol. 16
Open Access
Advances in CAR optimization strategies based on CD28
Sijin Li, Yongning Zhou, Hairong Wang, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Enhanced cytotoxicity against cholangiocarcinoma by fifth-generation chimeric antigen receptor T cells targeting integrin αvβ6 and secreting anti-PD-L1 scFv
Nattaporn Phanthaphol, Chalermchai Somboonpatarakun, Kwanpirom Suwanchiwasiri, et al.
Journal of Translational Medicine (2025) Vol. 23, Iss. 1
Open Access
T-cell exhaustion in multiple myeloma
Krzysztof Żyłka, Tadeusz Kubicki, Lidia Gil, et al.
Expert Review of Hematology (2024) Vol. 17, Iss. 7, pp. 295-312
Closed Access | Times Cited: 1
Exploring the potential of the convergence between extracellular vesicles and CAR technology as a novel immunotherapy approach
O. Bar, Angel Porgador, Tomer Cooks
Journal of Extracellular Biology (2024) Vol. 3, Iss. 9
Open Access | Times Cited: 1
Long-Term Safety and Efficacy of the Fully Human CAR-T Therapy CT103A in Relapsed/Refractory Multiple Myeloma
Qiuxia Yu, D. Wang, Zhe Li, et al.
Molecular Therapy (2024)
Closed Access | Times Cited: 1
Novel immunotherapeutic approaches in lung cancer: driving beyond programmed death-1/programmed death ligand-1 and cytotoxic T-lymphocyte-associated Protein-4
Blerina Resuli, Diego Kauffmann-Guerrero
Current Opinion in Oncology (2024)
Closed Access | Times Cited: 1
Cancer Immunotherapy: Challenges and Advancements in CAR T Cell Technology
Pa‐thai Yenchitsomanus
Deleted Journal (2024) Vol. 76, Iss. 5, pp. 313-324
Open Access
Are we there yet? CAR‐T therapy in multiple myeloma
Eitan Mirvis, Reuben Benjamin
British Journal of Haematology (2024)
Open Access
Enhanced Cytotoxicity against Cholangiocarcinoma by Fifth-Generation Chimeric Antigen Receptor T Cells Targeting Integrin αvβ6 and Secreting Anti-PD-L1 scFv
Nattaporn Phanthaphol, Chalermchai Somboonpatarakun, Kwanpirom Suwanchiwasiri, et al.
Research Square (Research Square) (2024)
Closed Access
Page 1

Scroll to top